# GPT 5.2 Review - Reviewer 2/3 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-29T19:25:34.763565
**Review mode:** Parallel (3 independent reviewers)
**Response ID:** resp_01fb867bca50bc0100697ba581951c81a3befdeba6a0a8424b
**Tokens:** 22561 in / 4987 out
**Response SHA256:** 1f0a7e61473fd8a5

---

## Referee Report: “Roads, Crashes, and Substances: A Geocoded Atlas of Western US Traffic Fatalities”

This manuscript is positioned as a “data infrastructure” / “atlas” paper that integrates FARS fatal crashes (2001–2019) with OpenStreetMap attributes and marijuana policy timing, emphasizing geocoded precision and border-based designs. As written, it is a strong descriptive technical report, but it does **not** meet the standards of a top general-interest economics journal (or AEJ:EP) because it provides **no main statistical estimates with valid inference** and does **not execute** the identification strategies it motivates (DiD, spatial RDD). For a top outlet, the paper must either (i) become a fully-fledged causal empirical study with credible inference, or (ii) be reframed and relocated to a field journal where a descriptive atlas/data paper is an acceptable primary contribution.

Below I provide a demanding, comprehensive review.

---

# 1. FORMAT CHECK

### Length
- The PDF appears to be **~27 pages of main text** through “Acknowledgements” and “Conclusion” (page numbers visible up to 27), plus **References (p. 28)** and **Appendix figures (pp. ~29–31)**.
- **PASS** on the “≥25 pages excluding references/appendix” criterion.

### References coverage
- The bibliography is **too thin** for the scope. You cite a handful of relevant items (Anderson et al. 2013; Pacula et al. 2015; Cook et al. 2020; Keele & Titiunik 2015; Callaway & Sant’Anna 2021; Sun & Abraham 2021).
- For top journals this is **not adequate**: major methodological and substantive literatures are missing (details in Section 4 of this report).
- **FAIL (needs major expansion).**

### Prose vs bullets
- Major sections (Intro, Data, Discussion) are mostly in paragraphs. Bullets are used mainly for variable definitions and pipeline steps (Section 2, Appendix A), which is acceptable.
- However, several core sections read like documentation rather than a research paper, with many short, list-like paragraphs and “pattern 1/2/3” reporting.
- **Borderline PASS** on the strict bullet criterion, but the prose/narrative is not at top-journal level (see Section 5).

### Section depth (3+ substantive paragraphs each)
- **Section 1 (Introduction):** multiple paragraphs; **PASS**.
- **Section 2 (Data Sources and Integration):** deep and detailed; **PASS**.
- **Sections 3–7:** several are shallow or largely figure-walkthroughs. E.g.:
  - **3.1–3.3** are mostly “Figure X shows…” paragraphs with limited substantive interpretation.
  - **4 (Showcase: Zooming In)** is almost entirely figure narration; little analytical content beyond “visual inspection reveals…”.
  - **5 (Substance involvement)** is short relative to the importance of measurement/selection.
  - **6 (Policy border patterns)** is underdeveloped given the centrality of border designs.
- **FAIL overall**: multiple major sections do not have 3+ substantive paragraphs of analysis and interpretation.

### Figures (visible data, axes, quality)
- Time series plots (Figures 1, 3, 12) and bar charts (Figure 2, 13) have axes and appear interpretable.
- Maps (Figures 5–8) are visually sparse and **lack standard map elements** expected in top journals:
  - no latitude/longitude ticks (not strictly required but typical),
  - unclear basemaps/roads (ironic given OSM integration),
  - points without transparency/density handling; limited legend clarity,
  - some map panels look underutilized (lots of white space), suggesting plotting/layout issues.
- **PASS** on “shows visible data,” but **not publication quality**.

### Tables (real numbers)
- Table 1 and Table 2 contain real entries and coherent summary statistics.
- **PASS**.

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

A top economics journal paper **cannot pass** without statistical inference on key claims.

### a) Standard errors
- There are **no regression tables** and **no coefficients with SEs**. The manuscript reports descriptive differences (“~19% vs ~10%”) without uncertainty measures.
- **FAIL.**

### b) Significance testing
- No hypothesis tests, no permutation/randomization inference, no clustered SE-based tests, no placebo inference.
- **FAIL.**

### c) Confidence intervals
- One figure (Figure 11) mentions “95% CI,” but the paper does not define how these are computed (binomial? clustered? bootstrap? pooled across borders?) and there are no CIs for the main headline cross-state comparisons.
- **FAIL for main results.**

### d) Sample sizes
- N is reported for some figures (e.g., map panels) and some descriptive statements, but there are **no regression Ns** because there are no regressions.
- **FAIL relative to top-journal expectations** (Ns must be reported for all models; plus clear denominators for all rates).

### e) DiD with staggered adoption
- The paper discusses staggered DiD methods (Callaway–Sant’Anna; Sun–Abraham) in Section 8.2 but **does not estimate anything**.
- No evidence of avoiding TWFE bias, no group-time ATTs, no event-study plots with uncertainty, no choice of never-treated controls implemented.
- **FAIL.**

### f) RDD
- The paper motivates spatial RDD (Keele–Titiunik) but does not execute it.
- No bandwidth sensitivity, no McCrary density test (or spatial analogue), no covariate balance/continuity checks, no donut robustness, no border-segment fixed effects, no discussion of spatial HAC inference.
- **FAIL.**

**Bottom line on methodology:** As written, this is **unpublishable** in AER/QJE/JPE/ReStud/Ecta/AEJ:EP because it does not produce core estimates with credible inference. The current manuscript is closer to a replication/data note.

---

# 3. IDENTIFICATION STRATEGY

### Is identification credible?
- The manuscript *proposes* credible designs (spatial RDD at borders; staggered DiD) but **does not implement** them. Thus credibility cannot be evaluated, and the paper’s conclusions remain descriptive.

### Key assumptions discussed?
- Parallel trends and continuity are mentioned at a high level, but not analyzed:
  - No pre-trend/event study evidence for crash counts or alcohol outcomes around legalization timing.
  - No continuity checks in border plots (beyond visual discontinuities).
  - No testing/reporting selection model; no bounding or sensitivity analysis.

### Placebos / robustness
- None of the standard robustness checks expected for these designs are present:
  - DiD: placebo treatment dates; alternative control groups; alternative exposure (possession vs retail).
  - Spatial RDD: border-segment FE; different distance bandwidths; donut holes; covariate continuity; manipulation/sorting tests; spatial clustering of SEs.

### Do conclusions follow from evidence?
- The paper mostly avoids strong causal language, but some statements drift into causal insinuation (e.g., “sharp policy discontinuity motivates RDD designs that… estimate causal effects,” and discussion implying border differences reflect legalization).
- Given pervasive selection into drug testing and heterogeneity in reporting, the descriptive cross-state THC detection differences should be framed even more cautiously.

### Limitations
- Section 7 is a strength: it acknowledges missingness and selection issues. But it stops short of providing methods to address them.

---

# 4. LITERATURE (MISSING REFERENCES + BIBTEX)

The literature review is not adequate for a top outlet. You need to cite (and engage with) (i) foundational DiD/RDD methodology, (ii) modern policy evaluation pitfalls, (iii) the marijuana–traffic safety empirical literature, and (iv) measurement papers on FARS drug testing and THC detection/impairment.

Below are specific additions with short explanations and BibTeX entries.

---

## A. Difference-in-differences (staggered adoption, event studies, pitfalls)

1) **Goodman-Bacon (2021)** — decomposition of TWFE under staggered adoption; essential for explaining why you will not use naive TWFE.
```bibtex
@article{GoodmanBacon2021,
  author  = {Goodman-Bacon, Andrew},
  title   = {Difference-in-Differences with Variation in Treatment Timing},
  journal = {Journal of Econometrics},
  year    = {2021},
  volume  = {225},
  number  = {2},
  pages   = {254--277}
}
```

2) **Roth et al. (2023)** — pre-trends, parallel trends diagnostics, event-study credibility.
```bibtex
@article{RothSantAnnaBilinskiPoe2023,
  author  = {Roth, Jonathan and Sant'Anna, Pedro H. C. and Bilinski, Alyssa and Poe, John},
  title   = {What's Trending in Difference-in-Differences? A Synthesis of the Recent Econometrics Literature},
  journal = {Journal of Econometrics},
  year    = {2023},
  volume  = {235},
  number  = {2},
  pages   = {2218--2244}
}
```

3) **Borusyak, Jaravel & Spiess (2021)** — imputation/event-study estimation with staggered adoption; widely used.
```bibtex
@article{BorusyakJaravelSpiess2021,
  author  = {Borusyak, Kirill and Jaravel, Xavier and Spiess, Jann},
  title   = {Revisiting Event Study Designs: Robust and Efficient Estimation},
  journal = {arXiv preprint arXiv:2108.12419},
  year    = {2021}
}
```

4) **Abadie (2005)** — semiparametric DiD; also useful for grounding identification language.
```bibtex
@article{Abadie2005,
  author  = {Abadie, Alberto},
  title   = {Semiparametric Difference-in-Differences Estimators},
  journal = {Review of Economic Studies},
  year    = {2005},
  volume  = {72},
  number  = {1},
  pages   = {1--19}
}
```

---

## B. Regression discontinuity (including geographic/spatial)

1) **Lee & Lemieux (2010)** — canonical RD review; must-cite if you claim RD credibility.
```bibtex
@article{LeeLemieux2010,
  author  = {Lee, David S. and Lemieux, Thomas},
  title   = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year    = {2010},
  volume  = {48},
  number  = {2},
  pages   = {281--355}
}
```

2) **Imbens & Lemieux (2008)** — practical RD guide.
```bibtex
@article{ImbensLemieux2008,
  author  = {Imbens, Guido W. and Lemieux, Thomas},
  title   = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year    = {2008},
  volume  = {142},
  number  = {2},
  pages   = {615--635}
}
```

3) **Calonico, Cattaneo & Titiunik (2014)** — robust bias-corrected inference; essential if you run RD.
```bibtex
@article{CalonicoCattaneoTitiunik2014,
  author  = {Calonico, Sebastian and Cattaneo, Matias D. and Titiunik, Rocio},
  title   = {Robust Nonparametric Confidence Intervals for Regression-Discontinuity Designs},
  journal = {Econometrica},
  year    = {2014},
  volume  = {82},
  number  = {6},
  pages   = {2295--2326}
}
```

4) **Cattaneo, Idrobo & Titiunik (2020)** — RD book; appropriate if RD is central.
```bibtex
@book{CattaneoIdroboTitiunik2020,
  author    = {Cattaneo, Matias D. and Idrobo, Nicolas and Titiunik, Rocio},
  title     = {A Practical Introduction to Regression Discontinuity Designs: Foundations},
  publisher = {Cambridge University Press},
  year      = {2020}
}
```

5) **McCrary (2008)** — density test (manipulation) you explicitly require in your own standard.
```bibtex
@article{McCrary2008,
  author  = {McCrary, Justin},
  title   = {Manipulation of the Running Variable in the Regression Discontinuity Design: A Density Test},
  journal = {Journal of Econometrics},
  year    = {2008},
  volume  = {142},
  number  = {2},
  pages   = {698--714}
}
```

---

## C. Marijuana legalization and traffic safety (substantive empirical literature)

You cite Anderson et al. (2013) and Cook et al. (2020), but you need to cover the broader landscape including recreational legalization and crashes/fatalities.

1) **Aydelotte et al. (2017)** — early widely-cited work on Colorado legalization and traffic fatalities; not necessarily causal-perfect, but central to the policy debate.
```bibtex
@article{Aydelotte2017,
  author  = {Aydelotte, Jayson D. and Brown, Lawrence H. and Luftman, Kathleen M. and Mardock, Adam L. and Teixeira, Paxton G. and Coopwood, T. Bryan and Brown, C. V. R.},
  title   = {Crash Fatality Rates After Recreational Marijuana Legalization in Washington and Colorado},
  journal = {American Journal of Public Health},
  year    = {2017},
  volume  = {107},
  number  = {8},
  pages   = {1329--1331}
}
```

2) **Hansen, Miller & Weber (2020)** — recreational marijuana and traffic fatalities (if you can locate exact final citation details; there are multiple versions/venues). At minimum, you need to cite leading econ work directly on recreational laws, not only medical.

3) **Smart & Pacula (2019/2021)** style work — Pacula-related work on marijuana policy heterogeneity and outcomes (you already cite Pacula et al. 2015, but not the more recent recreational-era evaluations).

Because details vary by working paper/publication, you should ensure you cite the definitive published versions you rely on.

---

## D. Measurement and selection in FARS drug testing / THC impairment

This is central to your paper (Section 7), yet citations are sparse. You need measurement-focused sources on:
- FARS toxicology completeness and heterogeneity,
- THC detection vs impairment,
- postmortem toxicology issues,
- state-level testing regimes.

Examples to add (you will need to verify final bibliographic details you are using):
- NHTSA technical reports on drug testing in fatals,
- review articles in epidemiology/traffic safety on THC pharmacokinetics and impairment.

(At present, the paper asserts key measurement facts with little citation support beyond Romano et al. 2017.)

---

# 5. WRITING QUALITY (CRITICAL)

### a) Prose vs bullets
- You mostly comply with paragraph form. Variable-definition bullets are fine.
- The larger issue is **genre**: Sections 3–6 read like a “figure catalog” rather than a paper with a central argument, economic mechanism, and empirical contribution.

### b) Narrative flow
- The Introduction has a clear motivation and states the data contribution.
- But the manuscript does not deliver a strong arc from **question → challenge → solution → validation → new empirical insight**. Instead it goes: “we built a dataset; here are maps; here are some patterns.”
- Top journals typically require either:
  1) a major new dataset plus **validation + a flagship empirical application with inference**, or
  2) a major methodological/data innovation that changes how research is done, again with evidence and benchmarking.

### c) Sentence quality
- Generally clear, but repetitive (“Figure X shows…”, “Visual inspection reveals…”).
- Too many claims are left at the level of qualitative observation, which is not persuasive in economics outlets.

### d) Accessibility
- Non-specialists will struggle with FARS drug-record definitions and selection without more intuition and a clear “workflow diagram” plus a single coherent conceptual framework for measurement.

### e) Figures/tables as standalone objects
- Many figures have decent captions, but key definitional issues (denominator selection, drug record meaning, state heterogeneity) should be reiterated in figure notes more explicitly and consistently.
- Maps need substantial redesign to meet publication standards.

---

# 6. CONSTRUCTIVE SUGGESTIONS (WHAT WOULD MAKE THIS TOP-JOURNAL READY)

To be viable at AEJ:EP or a top-5, you need to add a **real empirical core** with credible inference and a clear economic question. Concretely:

## A. Provide a flagship causal analysis (not only “motivating designs”)
Pick **one** main estimand and execute it end-to-end.

### Option 1: Staggered DiD on fatal crash counts / alcohol involvement (2001–2019)
- Unit: county-month or county-year (or border-corridor segments), with population/VMT offsets.
- Treatment: recreational possession legal date; separately retail opening.
- Estimator: Callaway–Sant’Anna group-time ATT + event-study with uniform confidence bands.
- Outcomes:
  - fatal crashes per VMT (preferred) or per population,
  - alcohol-involved fatal crashes (drunk_dr>0),
  - nighttime crashes, weekend nighttime, etc. (mechanisms).
- Inference: clustered SEs (state or county); consider randomization inference for state-level policies due to small treated clusters.

### Option 2: Spatial RDD at borders (2018–2019 for THC; longer window for crash counts/alcohol)
- Running variable: signed distance to nearest legal/illegal border along relevant border segments.
- Key requirements:
  - bandwidth sensitivity (multiple bandwidths),
  - donut hole (exclude crashes extremely near border if geocoding error),
  - border-segment fixed effects (avoid pooling incomparable borders),
  - covariate continuity checks (road type mix, time-of-day, local population density),
  - a manipulation/sorting test analogue (McCrary-style density in distance; plus checks for discontinuities in reporting/testing rates),
  - spatial HAC/Conley SEs or clustering by border segment.

## B. Deal with drug-testing selection explicitly (this is essential)
Right now you correctly warn about selection, but you do not quantify it.

Minimum expectations:
- Report “any drug record” rate and “any drug finding” rate as outcomes, and test whether legalization changes reporting/testing.
- Provide bounds/sensitivity:
  - inverse probability weighting for having a drug record (predictors: state, year, survival status, rurality, crash type),
  - Lee bounds if selection monotonicity is plausible,
  - show robustness restricting to crashes where driver died (more likely tested) vs survived.

## C. Validate geocoding + road snapping
- Provide empirical validation:
  - distribution of snap distances by state/year,
  - sensitivity excluding crashes with snap distance > 50m/100m/200m,
  - compare FARS functional class vs OSM highway type concordance.

## D. Clarify estimands and denominators
Your key THC fact is currently:
- “Among crashes with any drug record in 2018–2019, THC detected is 19% in legal vs 10% in comparison states.”

You must also show:
- THC-positive per all fatal crashes (even if biased), and
- THC-positive per tested crashes (define “tested” consistently, excluding “test not given”), and
- how these move with legalization.

## E. Improve presentation for a general-interest journal
- Add a conceptual framework section: why legalization could affect fatalities (use vs enforcement vs substitution vs exposure).
- Reduce the number of “map showcase” figures; keep 1–2 best ones and move the rest to appendix.
- Replace qualitative “visible discontinuity” language with actual discontinuity estimates and uncertainty.

---

# 7. OVERALL ASSESSMENT

### Key strengths
- Valuable integration of FARS with OSM and policy timing; replication pipeline is potentially a public good.
- Continuous 2001–2019 coverage is useful, especially for early legalizers.
- The paper is unusually explicit about drug-record limitations (Section 7), which is commendable.

### Critical weaknesses
- **No statistical inference / no estimated causal effects**; fails core publication requirements for top economics journals.
- Identification strategies are **proposed but not executed** (no DiD, no RD).
- Literature is **incomplete** for both methods and substantive domain.
- Maps/figures are not yet at publication quality, and several sections are too thin/figure-driven.

### Specific actionable fixes
1) Add a main empirical design (DiD or spatial RDD) with coefficient tables, SEs, CIs, Ns, and robustness.
2) Add explicit selection analysis for drug records/testing.
3) Expand citations substantially (see Section 4).
4) Tighten narrative, reduce “atlas” feel, and elevate the economic contribution beyond “here is a dataset.”

---

DECISION: REJECT AND RESUBMIT